NCT06249581View on ClinicalTrials.gov

Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

February 8, 2024

Study Completion Date

February 10, 2024

Conditions
Chronic Stable Angina
Interventions
DRUG

AUX-001 40mg once-daily

AUX-001 (extended-release nicorandil) 40mg QD (once-daily)

Trial Locations (1)

4250-449

BlueClinical, Porto

Sponsors
All Listed Sponsors
lead

Auxilius Pharma sp.z.o.o.

INDUSTRY